HER2/Neu GP2 vaccine

Drug Profile

HER2/Neu GP2 vaccine

Alternative Names: GP2 peptide + GM-CSF vaccine; GP2 peptide - Antigen Express; HER2/Neu Peptide GP2; HER2/neu peptide vaccine

Latest Information Update: 20 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Antigen Express; Norwell Inc
  • Developer Antigen Express
  • Class Cancer vaccines; Peptide vaccines; Peptides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Breast cancer

Most Recent Events

  • 16 Nov 2015 Phase II development is ongoing in USA, Germany and Greece
  • 01 Jan 2007 Phase-II clinical trials in Breast cancer in Germany (Intradermal)
  • 01 Jan 2007 Phase-II clinical trials in Breast cancer in Greece (Intradermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top